Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
about
Lipid nanoparticles for targeted siRNA delivery - going from bench to bedsideLipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis.Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles.Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.Molecular determinants for cyclo-oligosaccharide-based nanoparticle-mediated effective siRNA transfection.Nanomedicine as an emerging platform for metastatic lung cancer therapy.Targeting specific cells in the brain with nanomedicines for CNS therapiesMiRNA-323-5p Promotes U373 Cell Apoptosis by Reducing IGF-1R.Harnessing nanomedicine for therapeutic intervention in glioblastoma.Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.Ionic Driven Embedment of Hyaluronic Acid Coated Liposomes in Polyelectrolyte Multilayer Films for Local Therapeutic Delivery.Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells.Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery.siRNA delivery: current trends and future perspectives.Multiplexed nanomedicine for brain tumors: nanosized Hercules to tame our Lernaean Hydra inside?Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma.Development a hyaluronic acid ion-pairing liposomal nanoparticle for enhancing anti-glioma efficacy by modulating glioma microenvironment.Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?Use of nanoparticles for glioblastoma treatment: a new approach.Suppression of the Smurf1 Expression Inhibits Tumor Progression in Gliomas.Progress and challenges towards targeted delivery of cancer therapeutics.Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.Development of bioactive materials for glioblastoma therapy.Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
P2860
Q26741449-42D7112E-37F7-4214-A4E8-BA7427629F1AQ30851435-89070F56-32D5-4423-A2CF-EF45A6890147Q36459323-F2079EAA-73F0-4BC6-A7B8-EF83740A8B17Q37625459-BC50BF19-E05B-4B2F-9489-C871E3A74ADAQ37641455-A232A8F3-575A-4D14-AEF6-CC294DE92264Q38287935-AF0B5A10-8D90-40F5-9C7E-BEECFDD41AEEQ38463092-935769D2-8113-426C-B518-EBB7F635C822Q38674279-C33AD8B4-9A2C-4B4B-A9D4-540AD9E14936Q38812606-7C484F80-F894-4E8A-9204-8C222519F25FQ38862946-DB5C391F-03EB-4917-95F1-6730FD420D61Q38889576-62B3A526-065B-49DB-9293-7352A764C38CQ38928173-AFA67437-023B-4A3D-A7D0-6802938D2F22Q39227810-86FAF9B6-C71B-4F2E-9264-DE971D5AFD0EQ41543808-EE019A06-3228-46B0-AFF0-B51F8E1A46EBQ41610063-6B24F6D7-5AC9-4045-88DC-9A3F15BFA6EEQ45869675-469BC008-2B68-459E-8DF8-06BAAB3DA12FQ47152520-5BABA43A-B539-48D4-8395-7FB5A5DFD789Q47274570-C5C1DD8D-0D9C-407B-BD2D-943E1BCEF531Q47568930-774FA1CF-48E7-42FC-90B4-C584843EAFA6Q47607623-CB10980B-2575-40AB-8920-ECF6CCA47CE3Q47720697-4847003E-E0DC-4295-B835-ED0D09014A53Q47834070-88CCB02A-4BDE-4BCA-90C1-687562D48A51Q47937284-938A2BD9-CE13-4927-8D21-5BCA50F56B5CQ48095060-CCF29F75-D3AC-489F-9DC5-A3D0BD0D65F1Q48254991-C6C9A49A-EF3B-42FB-BA68-A58F3A94A9A8Q52590993-11D27875-750F-4ED3-BB1E-6F75F4413804Q52649753-17D6AAC2-856F-4A62-BBB3-93E991A410BFQ54955140-C6524091-EFF1-4992-A916-C8FC9AB60AF2Q58105699-91123C26-1496-4E83-8EC1-64C4353D268F
P2860
Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@ast
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@en
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@nl
type
label
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@ast
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@en
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@nl
prefLabel
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@ast
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@en
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@nl
P2093
P356
P1433
P1476
Localized RNAi therapeutics of ...... ted lipid-based nanoparticles.
@en
P2093
Meir Goldsmith
Naama Peshes-Yaloz
Srinivas Ramishetti
Zion Zibly
Zvi R Cohen
P304
P356
10.1021/NN506248S
P407
P577
2015-01-08T00:00:00Z